These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding. Varani K; Gessi S; Dalpiaz A; Ongini E; Borea PA Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951 [TBL] [Abstract][Full Text] [Related]
3. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Asakura M; Asanuma H; Kim J; Liao Y; Nakamaru K; Fujita M; Komamura K; Isomura T; Furukawa H; Tomoike H; Kitakaze M Hypertens Res; 2007 Sep; 30(9):781-7. PubMed ID: 18037770 [TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes. Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243 [TBL] [Abstract][Full Text] [Related]
5. [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes. Varani K; Gessi S; Dionisotti S; Ongini E; Borea PA Br J Pharmacol; 1998 Apr; 123(8):1723-31. PubMed ID: 9605581 [TBL] [Abstract][Full Text] [Related]
6. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors. Noble F; Cox BM Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226 [TBL] [Abstract][Full Text] [Related]
7. Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A. Chern Y; Chiou JY; Lai HL; Tsai MH Mol Pharmacol; 1995 Jul; 48(1):1-8. PubMed ID: 7623763 [TBL] [Abstract][Full Text] [Related]
8. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261. Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of A2A adenosine receptor expression by TNF-alpha in PBMC of patients with CHF: a regulatory mechanism of inflammation. Capecchi PL; Camurri A; Pompella G; Mazzola A; Maccherini M; Diciolla F; Lazzerini PE; Abbracchio MP; Laghi-Pasini F J Card Fail; 2005 Feb; 11(1):67-73. PubMed ID: 15704067 [TBL] [Abstract][Full Text] [Related]
10. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Chern Y; Lai HL; Fong JC; Liang Y Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918 [TBL] [Abstract][Full Text] [Related]
11. A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and betagamma subunits formed after alpha2-adrenoceptor activation. Fresco P; Oliveira JM; Kunc F; Soares AS; Rocha-Pereira C; Gonçalves J; Diniz C Neurochem Int; 2007 Jul; 51(1):47-56. PubMed ID: 17493708 [TBL] [Abstract][Full Text] [Related]
12. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302 [TBL] [Abstract][Full Text] [Related]
13. Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261. Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E J Pharmacol Exp Ther; 1996 Sep; 278(3):1209-14. PubMed ID: 8819504 [TBL] [Abstract][Full Text] [Related]
15. Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease. Tarditi A; Camurri A; Varani K; Borea PA; Woodman B; Bates G; Cattaneo E; Abbracchio MP Neurobiol Dis; 2006 Jul; 23(1):44-53. PubMed ID: 16651003 [TBL] [Abstract][Full Text] [Related]
16. Localization of adenosine A2A-receptors in rat brain with [3H]ZM-241385. DeMet EM; Chicz-DeMet A Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):478-81. PubMed ID: 12382078 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of adenosine receptors in heart of diabetic rat. Grdeń M; Podgórska M; Szutowicz A; Pawełczyk T J Physiol Pharmacol; 2005 Dec; 56(4):587-97. PubMed ID: 16391416 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics. Martini C; Tuscano D; Trincavelli ML; Cerrai E; Bianchi M; Ciapparelli A; Alessio L; Novelli L; Catena M; Lucacchini A; Cassano GB; Dell'Osso L J Psychiatr Res; 2006 Feb; 40(1):81-8. PubMed ID: 16431220 [TBL] [Abstract][Full Text] [Related]
19. Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension. Varani K; Manfredini R; Iannotta V; Pancaldi C; Cattabriga E; Uluoglu C; Borea PA; Portaluppi F Hypertension; 2002 Dec; 40(6):909-13. PubMed ID: 12468578 [TBL] [Abstract][Full Text] [Related]
20. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Koshiba M; Rosin DL; Hayashi N; Linden J; Sitkovsky MV Mol Pharmacol; 1999 Mar; 55(3):614-24. PubMed ID: 10051547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]